📊 Score Breakdown
Offering Ability
60
Cash Runway
95
Float Risk
100
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
62%
🔄 Reverse Split
70%
• 50-day avg $0.39 below $1 exchange minimum
• Only 1 months cash — financial pressure
💰 Capital Raise
55%
• Critical: only 1.0 months cash remaining
📉 Score Deterioration
55%
• Score rose 47 points recently (worsening)
• Score already CRITICAL (78/100) — events likely imminent
💹 Market Data
Market Cap$143.46M
Shares Outstanding388.14M
Float15.89M
Cash$2.04M
Debt$1.55M
Short InterestN/A
🏛 Institutional Holdings
10 institutional holders · 3.50M shares
#1
CRCM LP
2.57M shares
#2
Citadel Advisors Llc
214.1K shares
#3
Geode Capital Management, LLC
178.0K shares
+ 7 more holders Sign up free to view →
📉 Short Interest
Short Interest413.1K
Days to Cover2.2
% of Float2.6%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Sep 30, 2025
xbrl
XBRL WARRANT
Sep 30, 2024
4
INSIDER TRANSACTION
Mar 26, 2026
4
INSIDER TRANSACTION
Mar 26, 2026
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for USBC
📊 USBC FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 USBC Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.